<DOC>
	<DOCNO>NCT01358227</DOCNO>
	<brief_summary>The purpose study determine side effect best weekly dose PR104 patient advance solid tumor .</brief_summary>
	<brief_title>A Phase I Dose Escalation Trial PR104 Given Weekly Subjects With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Age 18 year Histologically confirm malignancy effective therapy exist Measurable evaluable disease ECOG Performance Status 0 1 . See Section 15.1 ( ECOG performance status ) definition ECOG Performance Status 0 1 Ability read , understand provide write informed consent If subject systemic steroid , dose steroid must stable least two week prior first dose PR104 Licensed investigational anticancer therapy ( include radiotherapy ) within four week baseline disease assessment ( within six week nitrosoureas Mitomycin C ) . Subjects androgen deprivation therapy allow study may continue receive androgen deprivation therapy one study Prior radiotherapy 25 % bone marrow ; prior highdose chemotherapy ( include either myeloablative nonmyeloablative transplant ) ; prior receipt three chemotherapy regimens Absolute neutrophil count &lt; 1.5 x 109/L Platelet count &lt; 100 x 109/L Hemoglobin level &lt; 90 g/L ( require red blood cell transfusion maintain hemoglobin &gt; 90 g/L ) Serum bilirubin great upper limit normal ALT AST great 2.5 time upper limit normal Serum creatinine less 1.5 time upper limit normal Prothrombin time ( PTINR ) activate partial thromboplastin time ( APTT ) great 1.1 time upper limit normal range Women pregnant , breastfeed plan become pregnant study Men woman reproductivepotential unwilling use effective method contraception study 30 day follow last dose study medication . See section 5.11 ( Contraceptives ) definition effective method contraception Evidence significant medical disorder laboratory find opinion Investigator compromise subject 's safety study participation , include uncontrolled infection infection require concomitant parenteral antibiotic Plans concomitant anticancer therapy ( exclude androgen deprivation therapy ) study Less four week since major surgery Known HIV positive , Hepatitis B sAg positive Hepatitis C positive abnormal liver function test No known contraindication single dos naproxen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>